Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02034344 · ClinicalTrials.gov registry record
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
A clinical trial of Healthy and Lupus Erythematosus, Systemic, sponsored by Janssen Research & Development.
- Completed
- Registry status
- 77
- Enrollment target
- 20
- Study locations
NCT02034344: Completed study of Healthy and Lupus Erythematosus, Systemic, sponsored by Janssen Research & Development.
NCT02034344 is a study of Healthy and Lupus Erythematosus, Systemic that has completed, run by Janssen Research & Development. The registered enrollment target is 77 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower). The trial reports 20 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02034344, a study of Healthy and Lupus Erythematosus, Systemic, has completed, sponsored by Janssen Research & Development.
- COMPLETED
- Registry status
- 77 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to obtain skin, blood, and urine samples from patients with active cutaneous lupus lesions and from healthy participants.
Primary Outcome
Investigation of pathways which may be dysregulated in cutaneous lupus lesions
Conditions Studied
Interventions
- PROCEDURE Blood collection
- PROCEDURE Skin biopsy
- PROCEDURE Urine collection
Study Locations (20)
Other
- - Berlin
- - Kiel
- - Chihuahua City
- - Jalisco
- - Mexico City
- - Gdansk
- - Krakow
- - Wroclaw
- - Taichung
- - Taipei
- - Leeds
Pennsylvania
- - Duncansville
- - Philadelphia
California
- - La Jolla
Illinois
- - Chicago
Massachusetts
- - Boston
Michigan
- - Lansing
New Jersey
- - Neptune City
North Carolina
- - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-05 |
What the finished NCT02034344 record still lists
NCT02034344 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower).
The record links to 4 conditions, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Blood collection is the first listed.
NCT02034344 names 20 study sites across 9 states, led by Other, Pennsylvania, California.
Frequently Asked Questions
What is clinical trial NCT02034344 about?
NCT02034344 is a clinical study titled "A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers". The purpose of this study is to obtain skin, blood, and urine samples from patients with active cutaneous lupus lesions and from healthy participants.
What is the current status of trial NCT02034344?
This trial is currently completed. The enrollment target is 77 participants. The study started on 2013-10. Estimated completion is 2015-05.
What conditions does trial NCT02034344 study?
This clinical trial studies the following conditions: Healthy, Lupus Erythematosus, Systemic, Lupus Erythematosus, Discoid, Lupus Erythematosus, Cutaneous.
What interventions are being tested in trial NCT02034344?
The interventions under investigation include: Blood collection (PROCEDURE), Skin biopsy (PROCEDURE), Urine collection (PROCEDURE).
Who is sponsoring clinical trial NCT02034344?
This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02034344 being conducted?
This trial has 20 study locations across California, Illinois, Massachusetts, Michigan, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02034344's enrollment target sits among peer trials
77 291st of 1090 higher than 797 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia